# Effects of Hemodynamic Monitoring Using the ImaCor Single Use Transesophageal Echocardiography Probe in Critically Ill Patients

> **NCT02048566** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 550 (actual)

## Conditions studied

- Shock

## Interventions

- **DEVICE:** ImaCor PM
- **DEVICE:** ImaCor SM
- **OTHER:** Control PM
- **OTHER:** Control SM

## Key facts

- **NCT ID:** NCT02048566
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2017-10-19
- **Final completion:** 2018-05-01
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2018-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048566, "Effects of Hemodynamic Monitoring Using the ImaCor Single Use Transesophageal Echocardiography Probe in Critically Ill Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02048566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*